Clinical trials
Phase 1/2 Hematologic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 2 |
| Spark Therapeutics, Inc. | 2 |
| Astex Pharmaceuticals, Inc. | 1 |
| Atavistik Bio, Inc | 1 |
| Baylor College of Medicine | 1 |
| BioMarin Pharmaceutical | 1 |
| Celgene | 1 |
| Constellation Pharmaceuticals | 1 |
| Dren Bio | 1 |
| Editas Medicine, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 21 |
| Genetic Diseases, Inborn | 6 |
| Hemorrhagic Disorders | 5 |
| Multiple Myeloma | 5 |
| Blood Protein Disorders | 4 |
| Leukemia | 4 |
| Neoplasms | 4 |
| Neoplasms, Plasma Cell | 4 |
| Anemia, Sickle Cell | 3 |
| Blood Coagulation Disorders | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.